Insomnia and chronic pain patients can now find relief from innovative brain stimulation device
NEW YORK, May 19, 2014 /CNW/ - Fisher Wallace Laboratories announced today that it has received Health Canada approval of the Fisher Wallace Stimulator® medical device for the treatment of insomnia and chronic pain. Widely used in the United States, the Fisher Wallace Stimulator® has been cleared for the treatment of insomnia, anxiety, depression and chronic pain by the U.S. Food and Drug Administration (FDA) since 1991.
"Health Canada approval of the Fisher Wallace Stimulator® medical device is a significant milestone for Fisher Wallace Laboratories and for insomnia and chronic pain patients across Canada," said Charles Fisher, president of Fisher Wallace Laboratories. "It means that for many insomnia and chronic pain sufferers, relief is just 20-minutes away."
The Fisher Wallace Stimulator® is a portable, battery-powered medical device that delivers a gentle electrical current to the brain to stimulate neurotransmitters responsible for healthy sleep and pain suppression. The device is available without a prescription in Canada and patients can return it for a refund within 60 days of receipt if it does not relieve their symptoms.
Health Canada evaluated the safety and effectiveness of the Fisher Wallace Stimulator® based on data from multiple published studies involving hundreds of patients. Overall, published research and clinical practice indicate that the device has a 75% success rate in reducing or eliminating multiple forms of insomnia and chronic pain. No adverse events occurred during any study involving the device and the device causes no serious side effects.
Fisher Wallace Stimulator® is patented in the U.S.
Fisher Wallace Stimulator® is also available in the United States.
About the Fisher Wallace Laboratories
Fisher Wallace Laboratories is the world's leading manufacturer of cranial electrotherapy stimulation devices, also known as "electroceuticals," that have been cleared by the FDA and approved by Health Canada. www.fisherwallace.ca
SOURCE: Fisher Wallace Laboratories
For further information:
Kelly Roman, 917-930-4332